NCT05548452View on ClinicalTrials.gov

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 21, 2022

Primary Completion Date

November 30, 2026

Study Completion Date

December 30, 2026

Conditions
Liver Disease; Alcohol-RelatedCirrhosisAlcohol Use Disorder
Interventions
DRUG

Intestinal Microbiota Transplant (IMT) Capsules

Capsules containing freeze-dried intestinal microbiota from healthy human donors

DRUG

Placebo Capsules

"Capsules containing an inactive substance (sugar pill)"

Trial Locations (2)

23249

RECRUITING

Hunter Holmes McGuire VA Medical Center, Richmond

23298

RECRUITING

Virginia Commonwealth University, Richmond

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Virginia Commonwealth University

OTHER